Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q4753617> ?p ?o }
Showing triples 1 to 39 of
39
with 100 triples per page.
- Q4753617 subject Q7310239.
- Q4753617 subject Q8522216.
- Q4753617 subject Q8965786.
- Q4753617 subject Q9052323.
- Q4753617 abstract "Andarine (GTx-007, S-4) is an investigational selective androgen receptor modulator (SARM) developed by GTX, Inc for treatment of conditions such as muscle wasting, osteoporosis and benign prostatic hypertrophy, using the non-steroidal androgen antagonist bicalutamide as a lead compound.Andarine is an orally active partial agonist for androgen receptors. It is less potent in both anabolic and androgenic effects than other SARMs. In an animal model of benign prostatic hypertrophy, andarine was shown to reduce prostate weight with similar efficacy to finasteride, but without producing any reduction in muscle mass or anti-androgenic side effects. This suggests that it is able to competitively block binding of dihydrotestosterone to its receptor targets in the prostate gland, but its partial agonist effects at androgen receptors prevent the side effects associated with the anti-androgenic drugs traditionally used for treatment of BPH.".
- Q4753617 atcPrefix "none".
- Q4753617 casNumber "401900-40-1".
- Q4753617 drugbank "DB07423".
- Q4753617 iupacName "(2S)-3-(4-acetamido-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamide".
- Q4753617 pubchem "9824562".
- Q4753617 thumbnail Andarine.svg?width=300.
- Q4753617 wikiPageWikiLink Q14873015.
- Q4753617 wikiPageWikiLink Q165328.
- Q4753617 wikiPageWikiLink Q1988832.
- Q4753617 wikiPageWikiLink Q411054.
- Q4753617 wikiPageWikiLink Q424167.
- Q4753617 wikiPageWikiLink Q506659.
- Q4753617 wikiPageWikiLink Q5514784.
- Q4753617 wikiPageWikiLink Q574820.
- Q4753617 wikiPageWikiLink Q7310239.
- Q4753617 wikiPageWikiLink Q7365.
- Q4753617 wikiPageWikiLink Q7447756.
- Q4753617 wikiPageWikiLink Q770260.
- Q4753617 wikiPageWikiLink Q8522216.
- Q4753617 wikiPageWikiLink Q8965786.
- Q4753617 wikiPageWikiLink Q9052323.
- Q4753617 atcPrefix "none".
- Q4753617 casNumber "401900".
- Q4753617 drugbank "DB07423".
- Q4753617 iupacName "-3".
- Q4753617 pubchem "9824562".
- Q4753617 type ChemicalSubstance.
- Q4753617 type Drug.
- Q4753617 type ChemicalObject.
- Q4753617 type Thing.
- Q4753617 type Q8386.
- Q4753617 comment "Andarine (GTx-007, S-4) is an investigational selective androgen receptor modulator (SARM) developed by GTX, Inc for treatment of conditions such as muscle wasting, osteoporosis and benign prostatic hypertrophy, using the non-steroidal androgen antagonist bicalutamide as a lead compound.Andarine is an orally active partial agonist for androgen receptors. It is less potent in both anabolic and androgenic effects than other SARMs.".
- Q4753617 label "Andarine".
- Q4753617 depiction Andarine.svg.